Darr Amber Y, Gottfried Sarah
Department of Pharmacy Practice, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, USA.
Walreens, Purcellville, USA.
SAGE Open Med. 2020 Jun 20;8:2050312120935461. doi: 10.1177/2050312120935461. eCollection 2020.
While pharmacists have provided vaccinations to patients in the community pharmacy setting, pharmacist involvement within the medical office setting is not well documented in the literature. The American Society of Health-System Pharmacists reports that ambulatory care pharmacists are screening for and administering vaccinations at a declining rate, despite standards of practice. Vaccination rates for adults 19-64 years of age remain low, based on Healthy People 2020 goals, putting them at risk for vaccine-preventable diseases.
The aim of the study was to assess vaccination rates of ambulatory care pharmacy clinic patients aged 19-64 years and to compare the rates between three clinics and to Healthy People 2020 goals.
This was a baseline retrospective analysis of vaccination rates for patients aged 19-64 years who attended at least one pharmacy clinic visit at one of the three medical office practices. Age, sex, medical conditions, cigarette or alcohol use, immunosuppressive medications, and vaccines recommended and received were recorded. Vaccination status was assessed according to the Advisory Committee for Immunization Practices recommendations. Data were collected from January 2016 to March 2017. The percentage of eligible patients who received each vaccine was determined overall and for each clinic.
There were 240 patients who met the inclusion criteria, with a mean age of 52.8 years. The percentage of patients with vaccination documented in the medical record was 25% for pneumococcal conjugate, 35.7% for pneumococcal polysaccharide, 26.9% for zoster vaccine live, 6.4% for hepatitis B, and 50.6% for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis. Vaccination rates for pneumococcal conjugate, pneumococcal polysaccharide, and zoster vaccine live were below established Healthy People 2020 goals.
Vaccination rates remain low in adults 19-64 years of age. Ambulatory care pharmacists should consider assessing vaccination status during clinic visits as a component of comprehensive vaccination programs.
虽然药剂师已在社区药房环境中为患者提供疫苗接种服务,但药剂师在医疗办公室环境中的参与情况在文献中记录较少。美国卫生系统药师协会报告称,尽管有执业标准,但门诊护理药师进行疫苗接种筛查和接种的比例正在下降。根据《健康人民2020》目标,19至64岁成年人的疫苗接种率仍然很低,这使他们面临可通过疫苗预防疾病的风险。
本研究的目的是评估19至64岁门诊护理药房诊所患者的疫苗接种率,并比较三个诊所之间的接种率以及与《健康人民2020》目标的差异。
这是一项对在三个医疗办公室机构中至少就诊过一次药房诊所的19至64岁患者的疫苗接种率进行的基线回顾性分析。记录年龄、性别、医疗状况、吸烟或饮酒情况、免疫抑制药物以及推荐和接种的疫苗。根据免疫实践咨询委员会的建议评估疫苗接种状况。数据收集时间为2016年1月至2017年3月。确定了总体以及每个诊所中接种每种疫苗的符合条件患者的百分比。
有240名患者符合纳入标准,平均年龄为52.8岁。医疗记录中记录的肺炎球菌结合疫苗接种患者百分比为25%,肺炎球菌多糖疫苗为35.7%,带状疱疹活疫苗为26.9%,乙肝疫苗为6.4%,破伤风类毒素、白喉类毒素减少和无细胞百日咳疫苗为50.6%。肺炎球菌结合疫苗、肺炎球菌多糖疫苗和带状疱疹活疫苗的接种率低于既定的《健康人民2020》目标。
19至64岁成年人的疫苗接种率仍然很低。门诊护理药师应考虑在诊所就诊期间评估疫苗接种状况,作为全面疫苗接种计划的一部分。